Permethrin and Bumetanide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Permethrin (permethrin) and Bumetanide (bumetanide). Common drug interactions include body height decreased among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Permethrin and Bumetanide. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Permethrin?

Permethrin has active ingredients of permethrin. It is often used in scabies. eHealthMe is studying from 1,547 Permethrin users. Check the latest studies of Permethrin.

What is Bumetanide?

Bumetanide has active ingredients of bumetanide. It is often used in fluid retention. eHealthMe is studying from 20,532 Bumetanide users. Check the latest studies of Bumetanide.

On Jul, 14, 2026

19 people who take Permethrin and Bumetanide together, and have interactions are studied.

Permethrin and Bumetanide drug interactions.

What are the common drug interactions of Permethrin and Bumetanide, by gender? *:

female:

Body height decreased
Cellulitis (infection under the skin)
Hypoaesthesia (reduced sense of touch or sensation)
Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)
Renal failure (kidney dysfunction)
Spinal osteoarthritis (joint cartilage loss in spine)
Spondylitis (an inflammation of the vertebra with spinal cord involvement)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Asthenia (weakness)
Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)

male:

Chronic kidney disease
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Partner stress
Social problem
Blood creatinine increased
Bone density decreased
Constipation
Decreased activity
Hip arthroplasty

What are the common drug interactions of Permethrin and Bumetanide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Anaemia (lack of blood)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Emotional distress
Gait disturbance
Hyperkalaemia (damage to or disease of the kidney)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Pain
Partner stress
Renal failure (kidney dysfunction)

40-49:

Chronic kidney disease
Osteonecrosis (death of bone)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Blood creatinine increased
Bone density decreased
Emotional distress
Hip arthroplasty
Pain
Renal impairment (severely reduced kidney function)

50-59:

Chronic kidney disease
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Decreased activity
Emotional distress
Impaired work ability
Pain
Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
Quality of life decreased
Renal failure (kidney dysfunction)

60+:

Body height decreased
Cellulitis (infection under the skin)
Drug ineffective
Emotional disorder
Insomnia (sleeplessness)
Renal failure (kidney dysfunction)
Suicidal ideation
Visual impairment
Cardiac failure congestive
Constipation

What are the existing conditions these people have? *

Pain: 6 people, 31.58%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 26.32%
Hiv Infection: 5 people, 26.32%
Bladder Disorder: 4 people, 21.05%
Type 2 Diabetes: 3 people, 15.79%
Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 15.79%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 15.79%
Depression: 3 people, 15.79%
Diabetes: 3 people, 15.79%
Irritable Bowel Syndrome: 3 people, 15.79%

* Approximation only. Some reports may have incomplete information.

Do you take Permethrin and Bumetanide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously